Hovione and IDC Intranasal Drug Delivery Platform Available for Commercial Partnerships
Its lead single-use nasal dry powder device now available for commercial partnerships
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Its lead single-use nasal dry powder device now available for commercial partnerships
Hovione, the specialist integrated CDMO, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC.
Chemical companies, breweries, and perfumeries take to making and donating a vital commodity in short supply
Hovione today announced the appointment of Dr. Jean-Luc Herbeaux as Hovione’s Chief Executive Officer, effective 1st April 2022
Hovione has once again solidified its position as a top employer.
This certification is a recognition of Hovione´s resolve to put people first, and a validation that the investment in HR excellence is delivering.
Executiva, 23 February 2026